Stocks & Investing
Tue, September 17, 2024
[ Tue, Sep 17th 2024
] - WOPRAI
Thu, September 5, 2024
[ Thu, Sep 05th 2024
] - WOPRAI
Wed, August 14, 2024
[ Wed, Aug 14th 2024
] - WOPRAI
Mon, August 5, 2024
[ Mon, Aug 05th 2024
] - WOPRAI
Mon, July 22, 2024
[ Mon, Jul 22nd 2024
] - WOPRAI
Fri, June 28, 2024
[ Fri, Jun 28th 2024
] - WOPRAI
Tue, June 25, 2024
[ Tue, Jun 25th 2024
] - WOPRAI
Mon, June 17, 2024
[ Mon, Jun 17th 2024
] - WOPRAI
Thu, May 16, 2024
[ Thu, May 16th 2024
] - WOPRAI
Wed, May 15, 2024
[ Wed, May 15th 2024
] - WOPRAI
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Mon, March 25, 2024
[ Mon, Mar 25th 2024
] - WOPRAI
Tue, March 5, 2024
[ Tue, Mar 05th 2024
] - WOPRAI
Thu, February 29, 2024
[ Thu, Feb 29th 2024
] - WOPRAI
Thu, December 21, 2023
[ Thu, Dec 21st 2023
] - WOPRAI
Wed, December 20, 2023
[ Wed, Dec 20th 2023
] - WOPRAI
Mon, December 4, 2023
[ Mon, Dec 04th 2023
] - WOPRAI
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
Wed, November 1, 2023
[ Wed, Nov 01st 2023
] - WOPRAI
Mon, October 2, 2023
[ Mon, Oct 02nd 2023
] - WOPRAI
[ Mon, Oct 02nd 2023
] - WOPRAI
Wed, September 20, 2023
[ Wed, Sep 20th 2023
] - WOPRAI
Tue, September 5, 2023
[ Tue, Sep 05th 2023
] - WOPRAI
Wed, August 16, 2023
[ Wed, Aug 16th 2023
] - WOPRAI
Tue, August 15, 2023
[ Tue, Aug 15th 2023
] - WOPRAI
Tue, June 27, 2023
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
Fri, June 23, 2023
[ Fri, Jun 23rd 2023
] - WOPRAI
Wed, June 7, 2023
[ Wed, Jun 07th 2023
] - WOPRAI
Joon Lee Maintained (BMRN) at Strong Buy with Decreased Target to $90 on, Sep 17th, 2024
Joon Lee of Truist Securities, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $118 to $90 on, Sep 17th, 2024.
Joon has made no other calls on BMRN in the last 4 months.
There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Joon's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
- Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024
These are the ratings of the 6 analyists that currently disagree with Joon
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
- Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
